On September 12, 2021 Insmed Incorporated Inc. (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, reported that management will participate in the following virtual investor events (Press release, Insmed, SEP 1, 2021, View Source [SID1234587137]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual BioPharma Virtual Conference on September 8, 2021 at 9:45 a.m. ET in a fireside chat
The Morgan Stanley 19th Annual Global Healthcare Conference on September 9, 2021 at 3:30 p.m. ET in a fireside chat
The H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021 at 7:00 a.m. ET in a fireside chat available for on-demand viewing
SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines Event on September 22, 2021 in 1×1 investor meetings
The Cantor Fitzgerald Virtual Global Healthcare Conference on September 27, 2021 at 8:00 a.m. ET in a fireside chat
Each fireside chat will be webcast and can be accessed by visiting the investor relations section of the Company’s website at www.insmed.com. Each webcast will be archived for a period of 30 days following the respective presentation dates.